Multiple Sclerosis

Dr Burcu Zeydan Discusses How, Why Postrelapse Recovery Potential Declines With Older Age in MS

September 23rd 2020, 1:00pm


Relapse at an older age can significantly contribute to a worsening of multiple sclerosis (MS), explained Burcu Zeyda, MD, assistant professor of neurology, assistant professor of radiology, at Mayo Clinic.

Dr Patricia Coyle Underscores the Importance of Diagnosing and Treating MS Early

September 18th 2020, 9:00pm


Emerging data is showing that treatment within 6 months of presentation of multiple sclerosis (MS) is ideal, explained Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute.

Combined Training Program Improves Balance, Static Strength in Patients With MS

September 11th 2020, 7:30pm


Results of a combined training program in 17 patients with multiple sclerosis indicate patients reap benefits from daily activities like walking or sitting-to-standing, and show the program reduces the dual-task cost of performing cognitive tasks while walking.

Case Study Highlights Possible Relationship Between MS, IBD

September 5th 2020, 4:15pm


The authors suggest that recognizing the possible link may help identify patients at greater risk, although they do caution that larger studies are needed.

Engineered Gloves Show Promise at Measuring MS Limb Disability

September 4th 2020, 6:30pm


A small study says that gloves with sensors could measure impairments in hand function and may have advantages over standard methods.

Patients, Physicians Largely Agree on Presence of MS Relapse, Analysis Finds

August 29th 2020, 9:15pm


Patients were more likely to report more relapses of multiple sclerosis than physicians.

European Study Finds Patients With MS Adhere Better to Oral Therapies

August 23rd 2020, 1:00pm


Adherence to multiple sclerosis (MS) therapy is linked with improved clinical outcomes, better quality of life, lower health care costs, and other benefits.

FDA Approves Ofatumumab for Relapsing MS

August 21st 2020, 12:00pm


For multiple sclerosis, the therapy will be sold as Kesimpta by Novartis; it is administered by patients once a month through the Sensoready autoinjector pen.

THC, CBD Combo Eases MS Symptoms, Extends Cutaneous Silent Period

August 20th 2020, 3:30pm


A combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) relieved certain neurophysiological symptoms affecting patients with secondary progressive multiple sclerosis (MS).

Which Factors of MS Treatment Satisfaction Have Strongest Effect on HRQOL?

August 15th 2020, 10:45am


Certain aspects of satisfaction with multiple sclerosis (MS) treatment can impact health-related quality of life (HRQOL).